Introduction
CAP, death
COMMUNITY ACQUIRED PNEUMONIA
Administering supplemental vitamin C to treatment regimens for community acquired pneumonia (CAP) is an attractive option, but evidence of benefit is lackingThe published studies of the effect of vitamin C treatment on the outcome of CAP have been reviewed by the Cochrane collaboration, which identified one randomised controlled trial (N = 57)This study included patients with moderate and severe CAP. While the most secure endpoint to establish efficacy is death, the FDA has recommended an early clinical response of symptoms as an endpoint in clinical trials of CAPThis study was conducted to inform the design of a double-blind randomised controlled clinical trial embedded within routine ward based care in an acute tertiary care admitting hospital